Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-07-13

Clinical Trial Update: Neuroimaging of the Effects of Concerta in the Treatment of ADHD [Phase 4]

View source ↗

Summary

Phase 4 neuroimaging study evaluating the effects of Concerta in treating attention-deficit/hyperactivity disorder, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CONCERTA (METHYLPHENIDATE HYDROCHLORIDE)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Attention Deficit Disorder With Hyperactivity | Phase 4 | Status: COMPLETED | Results posted: 2012-07-13